Caris Life Sciences vs Triomics
Caris Life Sciences vs Triomics, compared side by side on 18 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Caris Life Sciences is on 59/100 and Triomics on 53/100.
Where each one leads
Caris Life Sciences
- our overall score: 59/100 against 53/100
- agent readiness: 47/100 against 30/100
- domain rating: 62/100 against 46/100
- headcount: 1,659 against 67
- funding raised: $700M against $22.0M
Triomics
- LinkedIn following: 131,499 against 77,698
At a glance
| Measure | Caris Life Sciences | Triomics |
|---|---|---|
| What it is | Caris Life Sciences is a leading innovator in molecular science, offering precision medicine solutions for cancer patients through advanced molecular profiling. | Advance every cancer decision. |
| Category | Biotech, MedTech, HealthTech, Genomics | Biotech, HealthTech, Drug Discovery, AI-Driven Protein Design |
| Sells toBusiness model | B2B | B2B |
| Offering | Services | Platform |
| Founded | 2008 | 2021 |
| Headquarters | Irving, United States | Cambridge, United States |
| Status | Active | Active |
Size, funding and growth
| Measure | Caris Life Sciences | Triomics |
|---|---|---|
| Employees | 1,659 | 67 |
| Total funding | $700M | $22.0M |
| Latest round | Series D | Series B |
| Valuation | $7.8B | Not published |
| LinkedIn followers | 77,698 | 131,499 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Caris Life Sciences | Triomics |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 59/100 | 53/100 |
| Traction | 60/100 | 55/100 |
| Search visibility | 22/100 | 33/100 |
| Quality | 78/100 | 68/100 |
| Agent readinessHow well an AI agent can read and act on the site | D (47/100) | F (30/100) |
| Domain ratingLink authority, 0-100 | 62/100 | 46/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Caris Life Sciences | Triomics |
|---|---|---|
| Hosting | Self Managed | Not detected |
| CDN | Not detected | Cloudflare |
| CMS | WordPress | Webflow |
| Analytics | Google Tag Manager | Not detected |
Caris Life Sciences vs Triomics: common questions
Which is better, Caris Life Sciences or Triomics?
On our 0-100 score Caris Life Sciences rates higher (59/100 against 53/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 18 data points above: read the rows that match what you are buying for.
How do Caris Life Sciences and Triomics compare on the numbers?
Caris Life Sciences leads on our overall score (59/100 against 53/100), agent readiness (47/100 against 30/100), domain rating (62/100 against 46/100), headcount (1,659 against 67), funding raised ($700M against $22.0M). Triomics leads on LinkedIn following (131,499 against 77,698).
Read the full Caris Life Sciences review and pricing or the Triomics review and pricing. You can also browse other Caris Life Sciences alternatives we track.